Moving Beyond EDI in Pharmaceutical Contracting and Chargebacks

In the pharmaceutical industry, contract updates, chargeback claims and credits are shared between trading partners through EDI 845, EDI 844 and EDI 849. Due to reliance on these EDI messages, roughly 4% of chargebacks result in errors causing revenue leakage, cash flow delays, and manual effort for everyone.

This guide explains why the time has come to move beyond EDI to blockchain-based solutions in pharma contracting and chargebacks.

  • EDI to blockchain-based solutions:
  • EDI 845 to Real-time & Aligned Contract Updates
  • EDI 844 to Blockchain Enforced Chargeback Accuracy
  • EDI 849 to Automatically Generated Credit Memos

Streamline contracting and chargebacks today!

Request Demo